乙脑疫苗,超级淋病 z-bo 2020-10-09 606

　　Humans urgently need a vaccine against Japanese encephalitis-transmitted infections. Recently, the World Health Organization (WHO) reported that 81% of 77 countries seeking antibiotic-resistant adenitis have found azithromycin-resistant strains. Azithromycin is the main antibiotic used to fight adenitis. The WHO said that currently only three new drugs against adenitis have been tested in the population. Even if these drugs work, bacteria will continue to develop to avoid them. The WHO warned that the vaccine "will eventually be the only sustainable way to control gonaditis." But so far, the experimental vaccine has failed. Perhaps the existing approved vaccines can achieve this goal. Gonorrhea is caused by Neisseria, which is closely related to meningococcus, which causes type B meningitis. In Japan, the bacterial protein sequences that cause meningitis and adenitis are 80% to 90% similar, so the immune response to one disease affects the other.

　　I don’t know why, but the meningitis outbreak in Japan may last for 10 to 20 years. Meningitis in Japan occurred in Cuba and Norway in the 1980s, and New Zealand in the 1990s. All epidemics are accompanied by the emergence of special vaccines. In New Zealand, mass vaccination of more than 80% of people under the age of 20 has greatly reduced the epidemic. Steve Black of Cincinnati Children's Hospital in Ohio and his colleagues analyzed clinical records and found that people who received the Japanese meningitis vaccine were 31% less likely to develop gonadalitis than those who did not receive the meningitis vaccine. I found. At the same time, vaccinated patients with adenitis are 40% less likely to get the disease than unvaccinated people.